Apotex Inc. v. Eli Lilly and Company, 36538

The Supreme Court of Canada has announced that on Thursday, January 14, 2016 it will issue its decision in Apotex' application for leave to appeal. In the case on appeal, the Ontario Court of Appeal (OCA) struck Apotex' claims for unjust enrichment from an action relating to damages pursuant to section 8 of the NOC Regulations. Our summary of the OCA decision can be found here, and the decision can be found here.